(Q33161210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Erika Berman-Rosenzweig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Shinichi Takatsuki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Warren Zuckerman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Daniela Brady

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Michelle Calderbank

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

D Dunbar Ivy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

17 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

published in

Pediatric Pulmonology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

27-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension.

29 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Ambrisentan for pulmonary arterial hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Clinical pharmacology of bosentan, a dual endothelin receptor antagonist

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Endothelin receptor antagonists in pulmonary arterial hypertension.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

The endothelin system in pulmonary arterial hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412194

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Ambrisentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22555

Ambrisentan for pulmonary arterial hypertension due to congenital heart disease

21 January 2018

1 reference

12 December 2020

Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension

1 reference

12 December 2020

Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1002/PPUL.22555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

22511577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22511577%20AND%20SRC:MED&resulttype=core&format=json